Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calprotectin Involvement in Emergency Hematopoiesis Observed in Severe COVID-19

NCT04953312 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04953312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04953312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calprotectin Involvement in Emergency Hematopoiesis Observed in Severe COVID-19
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2023
Completion date
July 31, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia, myelodysplastic syndromes, old age, severe/moderate coronavirus